Proficio Capital Partners LLC Purchases New Holdings in Pediatrix Medical Group, Inc. (NYSE:MD)

Proficio Capital Partners LLC acquired a new position in shares of Pediatrix Medical Group, Inc. (NYSE:MD) during the 4th quarter, according to its most recent 13F filing with the SEC. The fund acquired 30,780 shares of the company’s stock, valued at approximately $404,000.

A number of other institutional investors also recently made changes to their positions in MD. M&T Bank Corp increased its stake in shares of Pediatrix Medical Group by 16.2% in the fourth quarter. M&T Bank Corp now owns 99,090 shares of the company’s stock worth $1,300,000 after buying an additional 13,826 shares during the last quarter. Victory Capital Management Inc. grew its holdings in Pediatrix Medical Group by 95.8% during the 4th quarter. Victory Capital Management Inc. now owns 76,553 shares of the company’s stock worth $1,004,000 after acquiring an additional 37,463 shares in the last quarter. Bailard Inc. bought a new stake in shares of Pediatrix Medical Group in the 4th quarter worth about $161,000. Smartleaf Asset Management LLC increased its position in shares of Pediatrix Medical Group by 750.9% in the 4th quarter. Smartleaf Asset Management LLC now owns 6,901 shares of the company’s stock worth $91,000 after purchasing an additional 6,090 shares during the last quarter. Finally, Parkside Financial Bank & Trust raised its stake in shares of Pediatrix Medical Group by 36.1% in the 4th quarter. Parkside Financial Bank & Trust now owns 3,919 shares of the company’s stock valued at $51,000 after purchasing an additional 1,040 shares in the last quarter. 97.71% of the stock is owned by institutional investors and hedge funds.

Pediatrix Medical Group Trading Up 2.1 %

Shares of NYSE MD opened at $14.51 on Tuesday. The company has a market cap of $1.25 billion, a price-to-earnings ratio of -12.09, a price-to-earnings-growth ratio of 1.74 and a beta of 1.49. The stock’s 50 day simple moving average is $14.33 and its 200 day simple moving average is $13.58. The company has a current ratio of 1.60, a quick ratio of 1.42 and a debt-to-equity ratio of 0.81. Pediatrix Medical Group, Inc. has a 12-month low of $6.62 and a 12-month high of $17.67.

Pediatrix Medical Group (NYSE:MD) last announced its quarterly earnings results on Thursday, February 20th. The company reported $0.49 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.37 by $0.12. The company had revenue of $502.36 million during the quarter, compared to the consensus estimate of $486.22 million. Pediatrix Medical Group had a negative net margin of 4.92% and a positive return on equity of 15.47%. Equities research analysts expect that Pediatrix Medical Group, Inc. will post 1.38 EPS for the current year.

Wall Street Analyst Weigh In

Several brokerages recently weighed in on MD. StockNews.com raised Pediatrix Medical Group from a “hold” rating to a “buy” rating in a report on Wednesday, January 22nd. Truist Financial boosted their price target on Pediatrix Medical Group from $15.00 to $18.00 and gave the company a “hold” rating in a report on Friday, February 21st. Macquarie assumed coverage on Pediatrix Medical Group in a research note on Monday, December 16th. They set an “outperform” rating and a $18.00 price objective on the stock. Finally, UBS Group boosted their target price on shares of Pediatrix Medical Group from $16.50 to $18.50 and gave the company a “neutral” rating in a research note on Friday, February 21st. Four investment analysts have rated the stock with a hold rating and three have assigned a buy rating to the stock. According to data from MarketBeat, the company presently has a consensus rating of “Hold” and an average price target of $17.08.

Pediatrix Medical Group Profile

Pediatrix Medical Group, Inc, together with its subsidiaries, provides newborn, maternal-fetal, pediatric cardiology, and other pediatric subspecialty care services in the United States. It offers neonatal care services, such as clinical care to babies born prematurely or with complications within specific units at hospitals through neonatal physician subspecialists, neonatal nurse practitioners, and other pediatric clinicians.